Welcome to our dedicated page for PAYCHEX SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Paychex Inc. senior vice president Chad C. Parodi reported equity compensation changes. He received 2,727 restricted stock units, subject to vesting, and a new stock option for 18,471 shares at $110.00, exercisable beginning 2027-07-15 and expiring 2036-07-14. To cover taxes on vesting RSUs, 300 shares were withheld at $110.00, leaving him with 8,763 common shares held directly, plus multiple outstanding stock option awards.
Paychex VP, Controller & Treasurer Christopher C. Simmons sold 2,615 shares of common stock at $115.92 on July 17, 2026, leaving 3,420 shares held directly. On July 15, he received 1,818 restricted stock units under the Amended and Restated 2002 Stock Incentive Plan, with 1,172 shares withheld to satisfy related tax obligations, and was granted 11,082 stock options at a $110.00 exercise price exercisable from July 15, 2027 to July 14, 2036.
Adam Brooks Ante, Sr. Vice President, Paycor at Paychex, Inc., received equity awards and had shares withheld for taxes. He was granted 3,409 restricted stock units, subject to vesting, and stock options over 23,088 shares at an exercise price of $110.00 per share, exercisable from July 15, 2027 to July 14, 2036. Separately, 299 shares were disposed of at $110.00 per share to satisfy tax withholding obligations arising from restricted stock unit vesting. He now directly holds 55,975 common shares and also holds stock options over 14,767 shares at $140.68 per share expiring July 14, 2035.
PAYCHEX INC Chief Legal Officer and Secretary Prabha S. Bhandari reported a Form 4 transaction involving common stock and stock options. 282 shares of common stock were disposed of at $110.00 per share to satisfy tax withholding obligations upon the lapse of restrictions on restricted stock units, leaving 1,664 common shares held directly. The filing also reports outstanding stock options covering 7,383 shares of common stock at an exercise price of $140.68 expiring on July 14, 2035, and options over 7,558 shares at $121.63 expiring on July 14, 2034.
Paychex Sr. Vice President Elizabeth Roaldsen reported a tax-withholding disposition of 2,383 shares of common stock on July 15, 2026 at $110.0000 per share, to satisfy tax withholding obligations arising from lapse of restrictions applicable to restricted stock units, leaving 6,952 shares of directly owned stock. She also holds stock options for 11,518 shares at an exercise price of $140.6800 expiring July 14, 2035 and for 14,291 shares at $121.6300 expiring July 14, 2034, with additional option grants reported.
Paychex Inc. Sr. VP & CFO Robert L. Schrader reported equity compensation activity on 2026-07-15, including an award of 4,364 shares of common stock in the form of restricted stock units and a grant of 29,553 stock options with a 110.0000 per-share exercise price expiring 2036-07-14.
To satisfy tax obligations from vesting, 2,382 shares of common stock were withheld at 110.0000 per share. After these reported transactions, he directly held 21,147 common shares and indirectly held 339 shares through a 401(k), in addition to several earlier stock option awards.
A shareholder of Paychex, Inc. (PAYX) has filed a notice of proposed sale of 2,615 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an indicated aggregate value of $303,130.80.
The shares relate to restricted stock vesting events from the issuer, including 523 shares vesting on 08/15/2025, 67 shares vesting on 10/15/2025, and 2,025 shares vesting on 07/15/2026, which together correspond to the shares proposed for sale.
PAYCHEX INC chairman and director Martin Mucci exercised stock options to acquire 214,482 shares of common stock at $57.24 per share. On July 14, 2026, he delivered 163,329 shares to pay the exercise price or tax liability and sold 25,000 shares of common stock in open-market transactions at a weighted-average price of $109.93, with trades ranging from $109.55 to $110.225. Following these transactions, he held 444,200.3318 shares of common stock directly and retained multiple stock option grants, including 195,428 underlying shares at an exercise price of $73.53 expiring on July 14, 2030.
PAYCHEX INC senior executive Adam Brooks Ante reported a routine tax-related share disposition. On the non-derivative side, 2,678 shares of Common Stock were transferred at $102.71 per share to cover tax withholding obligations tied to vesting of restricted stock and restricted stock units. This was not an open-market sale. After this transaction, he directly holds 52,865 shares of Common Stock.
The filing also shows a Stock Option award over 14,767 underlying shares of Common Stock with an exercise price of $140.68 per share and an expiration date of July 14, 2035. These options remain outstanding as a direct holding.